KalVista Pharmaceuticals, Inc. (KALV)

SEC filing

KalVista Pharmaceuticals, Inc.

KALV · CIK 1348911

4 · Nov 26, 2025 · Yea Christopher sold 4,331 shares at $13.45/share ($58,256); exercised options for 6,875 shares

Yea Christopher sold 4,331 shares at $13.45/share ($58,256); exercised options for 6,875 shares

xslF345X05/form4-11262025_111117.xml

xslF345X05/form4-11262025_111117.xmlSEC.gov

Graphics and non-inline formats (not embedded below).